GENNIFER YOUNG: Open Payments
NPI 1326774977 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 55 payments from 11 companies in 2025. Trend: 2023 $467 · 2024 $1,108 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $284 |
| Alkermes, Inc. | 7 | $233 |
| Indivior Inc. | 7 | $227 |
| ABBVIE INC. | 10 | $188 |
| Janssen Pharmaceuticals, Inc | 4 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $156 |
| Teva Pharmaceuticals USA, Inc. | 4 | $154 |
| Bausch Health US, LLC | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
Products named: Auvelity, SUBLOCADE, VRAYLAR, CAPLYTA, AUSTEDO XR, LYBALVI, INVEGA SUSTENNA, ARISTADA.
Industry payments across FL — which companies pay providers there.
